Adam Gerstein
About Adam Gerstein
Adam Gerstein is the Co-Founder and CEO of Neurosmith AI, with over 15 years of experience in guiding startups. He has a strong background in finance, fundraising, and strategic execution, having previously held roles at Genesis Growth Partners and Innovate Labs.
Work at Neurosmith AI
Adam Gerstein currently serves as Co-Founder and CEO of Neurosmith AI, a position he has held since 2023. In this role, he focuses on leveraging artificial intelligence to drive innovation in the life sciences sector. His leadership aims to advance the development of digital biomarkers, particularly for Alzheimer's and other cognitive diseases, utilizing his extensive background in startups and technology.
Experience at Novo Venture Partners
Since 2017, Adam Gerstein has been the Director at Novo Venture Partners, located in the San Francisco Bay Area. In this capacity, he utilizes his expertise to guide early-stage ventures, emphasizing finance, fundraising, and strategic execution. His role involves identifying promising startups and providing them with the necessary resources and guidance to achieve growth.
Previous Roles and Achievements
Before his current positions, Adam Gerstein worked as Chief Operating Officer at Innovate Labs from 2016 to 2018 in the Greater Los Angeles Area. He also served as a Manager at Genesis Growth Partners from 2011 to 2016 in New York. His experience includes serving as a fractional COO and venture architect, where he has been instrumental in guiding startups through transformative phases.
Educational Background
Adam Gerstein studied at the University of California, Berkeley, where he earned a Bachelor of Science degree in Mechanical Engineering. This educational foundation has contributed to his analytical skills and technical knowledge, which he applies in his various roles within the startup ecosystem.
Startup Experience and Focus
With over 15 years of experience as a startup CxO, Adam Gerstein is a seasoned veteran in the startup landscape, having operated in five different startups. His focus lies in driving growth through finance, fundraising, and strategic execution, particularly in early-stage ventures across the life science, consumer, and B2B industries.